PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis.
Abstract
In this study we evaluate the antifibrotic properties of PG-490-88, a water-soluble derivative of triptolide. Triptolide is an oxygenated diterpene that is derived from a traditional Chinese herb that has potent immunosuppressive and antitumor activity.
We used the intratracheal bleomycin mouse model and found that PG490-88 inhibits fibrosis in the bleomycin group when given the same day or 5 days after bleomycin. PG490-88 also markedly reduced the number of myofibroblasts in the bleomycin treatment group.
An enzyme-linked immunosorbent assay of transforming growth factor (TGF)-beta in the bronchoalveolar lavage fluid showed a significant decrease in TGF-beta in the PG490-88-treated groups compared to the bleomycin-treated group. Additionally, triptolide blocked bleomycin-induced increase in TGF-beta mRNA in cultured normal human lung fibroblasts.
The efficacy of PG490-88 when administered late after bleomycin installation suggests a potential role in the treatment of idiopathic pulmonary fibrosis.
Research topics
Related publications
View all publications- Katikireddy CK, Krishna G, Berry G, Faul J, Kuschner W.Chest. 128(6):4013-7.2005 Dec 01
- Krishna G, Berry G, Kao P, Rosen G, Raffin TA.Clin Pulmon Med. 6(2):126-132.1999 Mar 01
- Hetzel J, Maldonado F, Ravaglia C, Wells AU, Colby TV, Tomassetti S, Ryu JH, Fruchter O, Piciucchi S, Dubini A, Cavazza A, Chilosi M, Sverzellati N, Valeyre D, Leduc D, Walsh SLF, Gasparini S, Hetzel M, Hagmeyer L, Haentschel M, Eberhardt R, Darwiche K, Yarmus LB, Torrego A, Krishna G, Shah PL, Annema JT, Herth FJF, Poletti V.Respiration. doi: 10.1159/000484055. [Epub ahead of print]2018 Jan 09
- Publication
The dying thoracic patient.
Krishna G, Raffin TA.Chest Surg Clin N Am. 8(3):723-39.1998 Aug 01 - Publication
Smoking cessation therapy with varenicline.
Mohanasundaram UM, Chitkara R, Krishna G.Int J Chron Obstruct Pulmon Dis. 2008;3(2):239-51.2008 Feb 01